The Role and Effect of Complementary and Alternative Medicine in Systemic Lupus Erythematosus

Rheumatic Disease Clinics of North America

Volumn 37, Issue 1, 2011, Pages 47-62

  Haija, Anan J ^a   Schulz, Steffan W ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Complementary and alternative medicine; Effectiveness; Systemic lupus erythematosus

Indexed keywords

ALLANTOIN; ALPHA TOCOPHEROL; ASCORBIC ACID; FISH OIL; GLUCOCORTICOID; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; PLACEBO; PRASTERONE; SUPEROXIDE DISMUTASE; VITAMIN D;

ABSENCE OF SIDE EFFECTS; ACUPUNCTURE; ALTERNATIVE MEDICINE; ANTIOXIDANT ACTIVITY; BEHAVIOR THERAPY; CLINICAL TRIAL (TOPIC); CULTURAL FACTOR; DIET SUPPLEMENTATION; DISEASE ACTIVITY; EDUCATIONAL STATUS; ETHNICITY; FATIGUE; FEEDBACK SYSTEM; HEALTH CARE NEED; HEALTH CARE SYSTEM; HERBAL MEDICINE; HUMAN; INCOME; INTERPERSONAL COMMUNICATION; KINESIOTHERAPY; MASSAGE; MEDICAL SPECIALIST; MEDITATION; PATIENT ATTITUDE; PATIENT CARE; PATIENT COUNSELING; PATIENT EDUCATION; PATIENT SATISFACTION; PRIORITY JOURNAL; PSYCHOLOGICAL WELL BEING; PSYCHOSOCIAL CARE; QUALITY OF LIFE; RELAXATION TRAINING; REVIEW; SEX DIFFERENCE; STRESS MANAGEMENT; SYSTEMIC LUPUS ERYTHEMATOSUS; VITAMIN SUPPLEMENTATION; YOGA;

ACUPUNCTURE THERAPY; BEHAVIOR THERAPY; DEMOGRAPHY; DIETARY SUPPLEMENTS; DISABILITY EVALUATION; EXERCISE THERAPY; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VITAMINS; YOGA;

EID: 78650951810     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2010.11.005     Document Type: Review

References (105)

1. Wallace D.J. The musculoskeletal system. Hahn BH, editor. Dubois' lupus erythematosus 2002, 629-644. Lippincott Williams & Wilkins, Philadelphia. 6th edition.
2. Sutcliffe N., Clarke A.E., Levinton C., et al. Associates of health status in patients with systemic lupus erythematosus. J Rheumatol 1999, 26(11):2352-2356.
3. Buskila D., Press J., Abu-Shakra M. Fibromyalgia in systemic lupus erythematosus: prevalence and clinical implications. Clin Rev Allergy Immunol 2003, 25(1):25-28.
4. Staud R. Are patients with systemic lupus erythematosus at increased risk for fibromyalgia?. Curr Rheumatol Rep 2006, 8(6):430-435.
5. Friedman A.W., Tewi M.B., Ahn C., et al. Systemic lupus erythematosus in three ethnic groups: XV. Prevalence and correlates of fibromyalgia. Lupus 2003, 12(4):274-279.
6. Goligher E.C., Pouchot J., Brant R., et al. Minimal clinically important difference for 7 measures of fatigue in patients with systemic lupus erythematosus. J Rheumatol 2008, 35(4):635-642.
7. Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria for Fatigue Measurement of fatigue in systemic lupus erythematosus: a systematic review. Arthritis Rheum 2007, 57(8):1348-1357.
8. Omdal R., Waterloo K., Koldingsnes W., et al. Fatigue in patients with systemic lupus erythematosus: the psychosocial aspects. J Rheumatol 2003, 30(2):283-287.
9. Bachen E.A., Chesney M.A., Criswell L.A. Prevalence of mood and anxiety disorders in women with systemic lupus erythematosus. Arthritis Rheum 2009, 61(6):822-829.
10. Freire E.A., Maia I.O., Nepomuceno J.C., et al. Damage index assessment and quality of life in systemic lupus erythematosus patients (with long-term disease) in Northeastern Brazil. Clin Rheumatol 2007, 26(3):423-428.
11. McElhone K., Abbott J., Teh L.S. A review of health related quality of life in systemic lupus erythematosus. Lupus 2006, 15(10):633-643.
12. Kuriya B., Gladman D.D., Ibañez D., et al. Quality of life over time in patients with systemic lupus erythematosus. Arthritis Rheum 2008, 59(2):181-185.
13. Jolly M. How does quality of life of patients with systemic lupus erythematosus compare with that of other common chronic illnesses?. J Rheumatol 2005, 32(9):1706-1708.
14. Moorthy L.N., Robbins L., Harrison M.J., et al. Quality of life in paediatric lupus. Lupus 2004, 13(4):234-240.
15. Maeshima E., Maeshima S., Mizobata R., et al. Life-style activities in systemic lupus erythematosus. Clin Exp Rheumatol 2007, 25(2):189-194.
16. Ward M.M., Marx A.S., Barry N.N. Psychological distress and changes in the activity of systemic lupus erythematosus. Rheumatology 2002, 41(2):184-188.
17. Mok C.C., Ho L.Y., Cheung M.Y., et al. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study. Scand J Rheumatol 2009, 38(2):121-127.
18. Zheng Y., Ye D.Q., Pan H.F., et al. Influence of social support on health-related quality of life in patients with systemic lupus erythematosus. Clin Rheumatol 2009, 28(3):265-269.
19. Engle E.W., Callahan L.F., Pincus T., et al. Learned helplessness in systemic lupus erythematosus: analysis using the rheumatology attitudes index. Arthritis Rheum 1990, 33(2):281-286.
20. Dobkin P.L., Da Costa D., Dritsa M., et al. Quality of life in systemic lupus erythematosus patients during more and less active disease states: differential contributors to mental and physical health. Arthritis Care Res 1999, 12(6):401-410.
21. Gladman D.D., Urowitz M.B., Gough J., et al. Fibromyalgia is a major contributor to quality of life in lupus. J Rheumatol 1997, 24(11):2145-2148.
22. Gladman D., Urowitz M., Fortin P., et al. Systemic lupus international collaborating clinics conference on assessment of lupus flare and quality of life measures in SLE. Systemic Lupus International Collaborating Clinics Group. J Rheumatol 1996, 23(11):1953-1955.
23. Ward M.M., Lotstein D.S., Bush T.M., et al. Psychosocial correlates of morbidity in women with systemic lupus erythematosus. J Rheumatol 1999, 26(10):2153-2158.
24. Sutcliffe N., Clarke A.E., Gordon C., et al. The association of socio-economic status, race, psychosocial factors and outcome in patients with systemic lupus erythematosus. Rheumatology 1999, 38(11):1130-1137.
25. Danoff-Burg S., Friedberg F. Unmet needs of patients with systemic lupus erythematosus. Behav Med 2009, 35(1):5-13.
26. Moses N., Wiggers J., Nicholas C. Persistence of unmet need for care among people with systemic lupus erythematosus: a longitudinal study. Qual Life Res 2008, 17(6):867-876.
27. Moore A.D., Petri M.A., Manzi S., et al. The use of alternative medical therapies in patients with systemic lupus erythematosus. Trination Study Group. Arthritis Rheum 2000, 43(6):1410-1418.
28. Alvarez-Nemegyei J., Bautista-Botello A. Complementary or alternative therapy use and health status in systemic lupus erythematosus. Lupus 2009, 18(2):159-163.
29. Alvarez-Nemegyei J., Bautista-Botello A., Dávila-Velázquez J. Association of complementary or alternative medicine use with quality of life, functional status or cumulated damage in chronic rheumatic diseases. Clin Rheumatol 2009, 28(5):547-551.
30. Leong K.P., Pong L.Y., Chan S.P. Why lupus patients use alternative medicine. Lupus 2003, 12(9):659-664.
31. Lee G.B., Charn T.C., Chew Z.H., et al. Complementary and alternative medicine use in patients with chronic diseases in primary care is associated with perceived quality of care and cultural beliefs. Fam Pract 2004, 21(6):654-660.
32. Ramos-Remus C., Gamez-Nava J.I., Gonzalez-Lopez L., et al. Use of alternative medicine in a consecutive sample of patients with systemic lupus erythematosus. J Rheumatol 1997, 24(12):2490-2491.
33. Mikhail N., Wali S., Ziment I., et al. Use of alternative medicine among Hispanics. J Altern Complement Med 2004, 10(5):851-859.
34. Panush R.S., for the Complementary and Alternative Therapies Subcommittee of the Communications and Marketing Committee American College of Rheumatology position statement: " complementary" and " alternative" therapies for rheumatic diseases 1998, American College of Rheumatology, Atlanta (GA).
35. Ghoname E.A., Craig W.F., White P.F., et al. Percutaneous electrical nerve stimulation for low back pain: a randomized crossover study. JAMA 1999, 281(9):818-823.
36. Scharf H., Mansmann U., Streitberger K., et al. Acupuncture and knee osteoarthritis. Ann Intern Med 2006, 145:12-20.
37. Gaw A.C., Chang L.W., Shaw L.C. Efficacy of acupuncture on osteoarthritic pain. A controlled, double-blind study. N Engl J Med 1975, 293(8):375-378.
38. Takeda W., Wessel J. Acupuncture for the treatment of pain of osteoarthritic knees. Arthritis Care Res 1994, 7(3):118-122.
39. Berman B.M., Lao L., Langenberg P., et al. Effectiveness of acupuncture as adjunctive therapy in osteoarthritis of the knee: a randomized, controlled trial. Ann Intern Med 2004, 141(12):901-910.
40. Vas J., Méndez C., Perea-Milla E., et al. Acupuncture as a complementary therapy to the pharmacological treatment of osteoarthritis of the knee: randomised controlled trial. BMJ 2004, 329(7476):1216.
41. Deluze C., Bosia L., Zirbs A., et al. Electroacupuncture in fibromyalgia: results of a controlled trial. BMJ 1992, 305(6864):1249-1252.
42. Martin D.P., Sletten C.D., Williams B.A., et al. Improvement in fibromyalgia symptoms with acupuncture: results of a randomized controlled trial. Mayo Clin Proc 2006, 81(6):749-757.
43. Witt C., Brinkhaus B., Jena S., et al. Acupuncture in patients with osteoarthritis of the knee: a randomized trial. Arthritis Rheum 2006, 54(11):3485-3493.
44. Capili B., Anastasi J.K., Geiger J.N. Adverse event reporting in acupuncture clinical trials focusing on pain. Clin J Pain 2010, 26(1):43-48.
45. Greco C.M., Kao A.H., Maksimowicz-McKinnon K., et al. Acupuncture for systemic lupus erythematosus: a pilot RCT feasibility and safety study. Lupus 2008, 17(12):1108-1116.
46. Arias A.J., Steinberg K., Banga A., et al. Systematic review of the efficacy of meditation techniques as treatments for medical illness. J Altern Complement Med 2006, 12(8):817-832.
47. Panjwani U., Selvamurthy W., Singh S.H., et al. Effect of Sahaja yoga meditation on auditory evoked potentials (AEP) and visual contrast sensitivity (VCS) in epileptics. Appl Psychophysiol Biofeedback 2000, 25(1):1-12.
48. Panjwani U., Selvamurthy W., Singh S.H., et al. Effect of Sahaja yoga practice on seizure control & EEG changes in patients of epilepsy. Indian J Med Res 1996, 103:165-172.
49. Janakiramaiah N., Gangadhar B.N., Naga Venkatesha Murthy P.J., et al. Antidepressant efficacy of Sudarshan Kriya Yoga (SKY) in melancholia: a randomized comparison with electroconvulsive therapy (ECT) and imipramine. J Affect Disord 2000, 57(1-3):255-259.
50. Woolery A., Myers H., Sternlieb B., et al. A yoga intervention for young adults with elevated symptoms of depression. Altern Ther Health Med 2004, 10(2):60-63.
51. Shannahoff-Khalsa D.S., Ray L.E., Levine S., et al. Randomized controlled trial of yogic meditation techniques for patients with obsessive-compulsive disorder. CNS Spectr 1999, 4(12):34-47.
52. Shapiro D.H. Adverse effects of meditation: a preliminary investigation of long-term meditators. Int J Psychosom 1992, 39(1-4):62-67.
53. Kennedy R.B. Self-induced depersonalization syndrome. Am J Psychiatry 1976, 133(11):1326-1328.
54. Dobkin P.L., Fortin P.R., Joseph L., et al. Psychosocial contributors to mental and physical health in patients with systemic lupus erythematosus. Arthritis Care Res 1998, 11(1):23-31.
55. McCracken L.M., Semenchuk E.M., Goetsch V.L., et al. Cross-sectional and longitudinal analyses of coping responses and health status in persons with systemic lupus erythematosus. Behav Med 1995, 20(4):179-187.
56. Karlson E.W., Daltroy L.H., Lew R.A., et al. The relationship of socioeconomic status, race, and modifiable risk factors to outcomes in patients with systemic lupus erythematosus. Arthritis Rheum 1997, 40(1):47-56.
57. Trupin L., Tonner M.C., Yazdany J., et al. The role of neighborhood and individual socioeconomic status in outcomes of systemic lupus erythematosus. J Rheumatol 2008, 35(9):1782-1788.
58. Jump R.L., Robinson M.E., Armstrong A.E., et al. Fatigue in systemic lupus erythematosus: contributions of disease activity, pain, depression, and perceived social support. J Rheumatol 2005, 32(9):1699-1705.
59. Bae S.C., Hashimoto H., Karlson E.W., et al. Variable effects of social support by race, economic status, and disease activity in systemic lupus erythematosus. J Rheumatol 2001, 28(6):1245-1251.
60. Sohng K.Y. Effects of a self-management course for patients with systemic lupus erythematosus. J Adv Nurs 2003, 42(5):479-486.
61. Bricou O., Taïeb O., Baubet T., et al. Stress and coping strategies in systemic lupus erythematosus: a review. Neuroimmunomodulation 2006, 13(5-6):283-293.
62. Karlson E.W., Liang M.H., Eaton H., et al. A randomized clinical trial of a psychoeducational intervention to improve outcomes in systemic lupus erythematosus. Arthritis Rheum 2004, 50(6):1832-1841.
63. Maisiak R., Austin J.S., West S.G., et al. The effect of person-centered counseling on the psychological status of persons with systemic lupus erythematosus or rheumatoid arthritis: a randomized, controlled trial. Arthritis Care Res 1996, 9(1):60-66.
64. Austin J.S., Maisiak R.S., Macrina D.M., et al. Health outcome improvements in patients with systemic lupus erythematosus using two telephone counseling interventions. Arthritis Care Res 1996, 9(5):391-399.
65. Peterson M.G., Horton R., Engelhard E., et al. Effect of counselor training on skills development and psychosocial status of volunteers with systemic lupus erythematosus. Arthritis Care Res 1993, 6(1):38-44.
66. Ng P., Chan W. Group psychosocial program for enhancing psychological well-being of people with systemic lupus erythematosus. J Soc Work Disabil Rehabil 2007, 6(3):75-87.
67. Haupt M., Millen S., Jänner M., et al. Improvement of coping abilities in patients with systemic lupus erythematosus: a prospective study. Ann Rheum Dis 2005, 64(11):1618-1623.
68. Greco C.M., Rudy T.E., Manzi S. Effects of a stress-reduction program on psychological function, pain, and physical function of systemic lupus erythematosus patients: a randomized controlled trial. Arthritis Rheum 2004, 51(4):625-634.
69. Geiger I., Langewitz W. Psychotherapy in a patient with lupus erythematodes, a disease with an uncertain course. Ther Umsch 2007, 64(10):581-584.
70. Dobkin P.L., Da Costa D., Joseph L., et al. Counterbalancing patient demands with evidence: results from a pan-Canadian randomized clinical trial of brief supportive-expressive group psychotherapy for women with systemic lupus erythematosus. Ann Behav Med 2002, 24(2):88-99.
71. Edworthy S.M., Dobkin P.L., Clarke A.E., et al. Group psychotherapy reduces illness intrusiveness in systemic lupus erythematosus. J Rheumatol 2003, 30(5):1011-1016.
72. Borba E., Bonfa E. Dyslipoproteinemias in systemic lupus erythematosus: influence of disease activity and anticardiolipin antibodies. Lupus 1997, 6(6):533-539.
73. Bultink I., Lems W., Kostense P., et al. Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus. Arthritis Rheum 2005, 52(7):2044-2050.
74. Keyser R.E., Rus V., Cade W.T., et al. Evidence for aerobic insufficiency in women with systemic lupus erythematosus. Arthritis Rheum 2003, 49(1):16-22.
75. Tench C., Bentley D., Vleck V., et al. Aerobic fitness, fatigue, and physical disability in systemic lupus erythematosus. J Rheumatol 2002, 29(3):474-481.
76. Houghton K.M., Tucker L.B., Potts J.E., et al. Fitness, fatigue, disease activity, and quality of life in pediatric lupus. Arthritis Rheum 2008, 59(4):537-545.
77. Ayán C., Martín V. Systemic lupus erythematosus and exercise. Lupus 2007, 16(1):5-9.
78. Volkmann E.R., Grossman J.M., Sahakian L.J., et al. Low physical activity is associated with proinflammatory high-density lipoprotein and increased subclinical atherosclerosis in women with systemic lupus erythematosus. Arthritis Care Res 2010, 62(2):258-265.
79. Carvalho M.R., Sato E.I., Tebexreni A.S., et al. Effects of supervised cardiovascular training program on exercise tolerance, aerobic capacity, and quality of life in patients with systemic lupus erythematosus. Arthritis Rheum 2005, 53(6):838-844.
80. Kipen Y., Briganti E., Strauss B., et al. Three year followup of bone mineral density change in premenopausal women with systemic lupus erythematosus. J Rheumatol 1999, 26:310-317.
81. Esposito K., Pontillo A., Di Palo C., et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 2003, 289(14):1799-1804.
82. Da Costa D., Bernatsky S., Dritsa M., et al. Determinants of sleep quality in women with systemic lupus erythematosus. Arthritis Rheum 2005, 53(2):272-276.
83. Häuser W., Klose P., Langhorst J., et al. Efficacy of different types of aerobic exercise in fibromyalgia syndrome: a systematic review and meta-analysis of randomised controlled trials. Arthritis Res Ther 2010, 12(3):R79.
84. Robb-Nicholson L.C., Daltroy L., Eaton H., et al. Effects of aerobic conditioning in lupus fatigue: a pilot study. Br J Rheumatol 1989, 28(6):500-505.
85. Daltroy L., Robb-Nicholson C., Iversen M., et al. Effectiveness of minimally supervised home aerobic training in patients with systemic rheumatic disease. Br J Rheumatol 1995, 34:1064-1069.
86. Ramsey R., Schilling E., Dunlop D., et al. A pilot study on the effects of exercise in patients with systemic lupus erythematosus. Arthritis Care Res 2000, 13(5):262-269.
87. Derksen R.H. Dehydroepiandrosterone (DHEA) and systemic lupus erythematosus. Arthritis Rheum 1998, 27(6):335-347.
88. Lahita R.G., Bradlow H.L., Ginzler E., et al. Low plasma androgens in women with systemic lupus erythematosus. Arthritis Rheum 1987, 30(3):241-248.
89. Van Vollenhoven R.F., Engleman E.G., McGuire J.L. An open study of dehydroepiandrosterone in systemic lupus erythematosus. Arthritis Rheum 1994, 37(9):1305-1310.
90. Petri M.A., Lahita R.G., Van Vollenhoven R.F., et al. Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial. Arthritis Rheum 2002, 46(7):1820-1829.
91. Nordmark G., Bengtsson C., Larsson A., et al. Effects of dehydroepiandrosterone supplement on health-related quality of life in glucocorticoid treated female patients with systemic lupus erythematosus. Autoimmunity 2005, 38(7):531-540.
92. Hartkamp A., Geenen R., Godaert G.L., et al. Effects of dehydroepiandrosterone on fatigue and well-being in women with quiescent systemic lupus erythematosus: a randomised controlled trial. Ann Rheum Dis 2010, 69(6):1144-1147.
93. Walton A.J., Snaith M.L., Locniskar M., et al. Dietary fish oil and the severity of symptoms in patients with systemic lupus erythematosus. Ann Rheum Dis 1991, 50(7):463-466.
94. Duffy E.M., Meenagh G.K., McMillan S.A., et al. The clinical effect of dietary supplementation with omega-3 fish oils and/or copper in systemic lupus erythematosus. J Rheumatol 2004, 31(8):1551-1556.
95. Wright S.A., O'Prey F.M., McHenry M.T., et al. A randomised interventional trial of omega-3-polyunsaturated fatty acids on endothelial function and disease activity in systemic lupus erythematosus. Ann Rheum Dis 2008, 67(6):841-848.
96. Damanhouri L.H. Vitamin D deficiency in Saudi patients with systemic lupus erythematosus. Saudi Med J 2009, 30(10):1291-1295.
97. Müller K., Kriegbaum N.J., Baslund B., et al. Vitamin D3 metabolism in patients with rheumatic diseases: low serum levels of 25-hydroxyvitamin D3 in patients with systemic lupus erythematosus. Clin Rheumatol 1995, 14(4):397-400.
98. Bogaczewicz J., Sysa-Jedrzejowska A., Arkuszewska C., et al. Pol Merkur Lekarski 2010, 28(164):103-107. [in Polish].
99. Wright T.B., Shults J., Leonard M.B., et al. Hypovitaminosis D is associated with greater body mass index and disease activity in pediatric systemic lupus erythematosus. J Pediatr 2009, 155(2):260-265.
100. Borba V.Z., Vieira J.G., Kasamatsu T., et al. Vitamin D deficiency in patients with active systemic lupus erythematosus. Osteoporos Int 2009, 20(3):427-433.
101. Ruiz-Irastorza G., Egurbide M.V., Olivares N., et al. Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences. Rheumatology 2008, 47(6):920-923.
102. Minami Y., Sasaki T., Arai Y., et al. Diet and systemic lupus erythematosus: a 4 year prospective study of Japanese patients. J Rheumatol 2003, 30(4):747-754.
103. Tam L.S., Li E.K., Leung V.Y., et al. Effects of vitamins C and E on oxidative stress markers and endothelial function in patients with systemic lupus erythematosus: a double blind, placebo controlled pilot study. J Rheumatol 2005, 32(2):275-282.
104. Weimann B.J., Hermann D. Inhibition of autoimmune deterioration in MRL/lpr mice by vitamin E. Int J Vitam Nutr Res 1999, 69(4):255-261.
105. Visser G.J., Peters L., Rasker J.J. Rheumatologists and their patients who seek alternative care: an agreement to disagree. Br J Rheumatol 1992, 31(7):485-490.